BPIQ-II

BPIQ-II, IUPAC name 8-[(3-Bromophenyl)amino]-1H-imidazo[4,5-γ]-quinazoline, is a small molecule chemical inhibitor of the epidermal growth factor receptor (EGFR), and presumably mediates inhibition of endogenous biological pathways for inhibition of axonal regeneration that are mediated through membraneous myelin and chondroitin sulfate proteoglycans.

Behind the Scenes

 * In the real world, was synthesized and characterized by Rewcastle et. al in 1996 at the University of Auckland School of Medicine in New Zealand and Parke-Davis Pharmaceutical Research in Michigan.
 * Article writer RelentlessRecusant found out about through his personal studies in chemical biology.